International Journal of Cardiovascular ResearchISSN: 2324-8602

Reach Us +1 850 900 2634
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Review Article, Int J Cardiovasc Res Vol: 2 Issue: 1

B2 Adrenergic Receptor Polymorphisms and Treatment- Outcomes in Cardiovascular Diseases

Habib Haybar1*, Mohammad Davoodi2, Ahmadreza Assareh1, Abtin Shahlaee3, Maryam Azarian4, Zahra Fazelinezhad2 and Amir Eslami Shahr Babaki5
1Cardiovascular Research Center, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran
2Radiology Group, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran
3Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
4Biology Group, North Tehran branch, Islamic Azad University, Tehran, Iran
5Sports Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
Corresponding author : Guido Iaccarino
Department of Medicine, University of Salerno, Via Salvador Allende, 84081, Baronissi, Salerno, Italy
E-mail: [email protected]
Received: December 12, 2012 Accepted: January 03, 2013 Published: January 21, 2013
Citation: Cipolletta E, Luca GD, Carillo AL, Annunziata R, Trimarco B, et al. (2013) β2 Adrenergic Receptor Polymorphisms and Treatment-Outcomes in Cardiovascular Diseases. Int J Cardiovasc Res 2:1. doi:10.4172/2324-8602.1000119

Abstract

B2 Adrenergic Receptor Polymorphisms and Treatment- Outcomes in Cardiovascular Diseases

Cardiovascular diseases (CVD) represent the major health problem in the western world and heavy social and economic burden. Under this name an eterogenous group of multifactorial conditions is included. There is appreciable inter-individual variability in the susceptibility to cardiovascular disease and in the response to the associated pharmacological treatments. Genetic polymorphism may be, at least in part, responsible for both susceptibility to disease and inter-individual variability in response to pharmacological treatments.

Keywords: β2 Adrenergic receptor; Polymorphism; Cardiovascular diseases

Track Your Manuscript

Share This Page

Media Partners